Us2.ca vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Us2.ca

by Eko.Ai Pte Ltd. D/B/A Us2.Ai

prolaio eVO2peak Module

by Prolaio

AI Verdict

These tools are adjacent in the cardiology AI space, but not direct competitors. Us2.ai specializes in fully automated echocardiography analysis for comprehensive cardiac structural and functional reporting, while Prolaio's eVO2peak Module estimates peak oxygen consumption using data from remote wearable sensors. Therefore, Us2.ai is suited for detailed diagnostic imaging analysis, whereas Prolaio is designed for physiological parameter estimation from continuous, real-world patient data.

Choose Us2.ca if…

Choose Us2.ai if your cardiology department or imaging center requires a solution to fully automate the analysis of echocardiograms, aiming to significantly improve diagnostic workflow efficiency and accuracy. This tool is ideal for rapidly generating comprehensive, structured cardiac reports with AI-powered disease detection for conditions like cardiac amyloidosis, heart failure, and aortic stenosis, integrating seamlessly with existing ultrasound devices and EMR systems.

View Us2.ca →

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if you need to remotely estimate and longitudinally track peak oxygen consumption (eVO2peak) for patients using data from FDA-cleared wearable sensors. This module is particularly well-suited for cardiovascular research, rehabilitation programs, or sports medicine applications where continuous, real-world data on functional capacity is crucial for adjunctive clinical evaluation.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Us2.ca	prolaio eVO2peak Module
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud, On-premise	Cloud-based (software-only, processes remote sensor data)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Us2.ca	prolaio eVO2peak Module
Name	Us2.ca	prolaio eVO2peak Module
Company	Eko.Ai Pte Ltd. D/B/A Us2.Ai	Prolaio
Primary Function	Fully automated echocardiography analysis, delivering comprehensive, structured cardiac reports.	Estimates peak oxygen consumption (eVO2peak) using real-world patient data.
Input Data/Methodology	Echocardiography analysis (zero clicks), real-time processing.	Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
Output/Report Type	Comprehensive, structured cardiac reports; AI-powered disease detection; guideline-based measurements and disease indication conclusions; editable annotations and visual overlays.	Provides information as an adjunctive aid in clinical evaluation; high-density, longitudinal data collection.
Specialties	Cardiology, Radiology	Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring Us2.ca and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

Us2.ai fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports and AI-powered disease detection for conditions like Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension. Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data from wearable sensors, serving as an adjunctive aid in clinical evaluation for cardiovascular research and care.

What type of patient data is required for each tool?

Us2.ai requires echocardiography images and data for its analysis. Prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.

How do these tools integrate into existing clinical workflows?

Us2.ai integrates with ultrasound devices, PACS, CVIS, and EMR systems, processing studies automatically and delivering structured reports back to these systems. Prolaio eVO2peak Module is a cloud-based software that processes remote sensor data from wearable medical sensors, providing information as an adjunctive aid in clinical evaluation.

What specific cardiac parameters or conditions does each tool help evaluate?

Us2.ai provides comprehensive cardiac structural and functional parameters (2D, Doppler, M-mode, strain imaging) and AI-powered disease detection for conditions such as Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension. Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) to be used as an adjunctive aid in clinical evaluation.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform